C

Candel Therapeutics
D

CADL

11.620
USD
-0.57
(-4.68%)
مغلق
حجم التداول
54,740
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
516,805,752
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Candel Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.